The results showed that BRAF V600E mutation abundance was significantly higher in the CLNM group than in the non-metastatic group (median 23% vs. 17%, p < 0.001), suggesting a close association between higher mutation abundance and lymph node metastasis. The gene discussed is BRAF; the disease is metastatic malignant neoplasm in the lymph nodes.